<DOC>
	<DOCNO>NCT00097552</DOCNO>
	<brief_summary>This study multicenter , open-label , observational , postmarketing surveillance study Genentech growth hormone ( GH ) product treatment girl Turner syndrome United States Canada .</brief_summary>
	<brief_title>A Study Evaluate Subjects With Turner Syndrome Treated With Growth Hormone</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Are girls Turner syndrome treat Nutropin , Nutropin AQ , Protropin Are willing keep followup appointment throughout study participation Are girls Turner syndrome submit Form 4 upon discontinuation may also submit Form 9 Have Noonan syndrome Subjects treat within last 6 month nonGenentech GH preparation Have close epiphysis prior NCGS enrollment Have active neoplasia</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>